Renalytix (RENX) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free RENX Stock Alerts GBX 27.10 -0.40 (-1.45%) (As of 08:20 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRenalytix (LON:RENX) Trading Down 4.6%americanbankingnews.com - April 17 at 1:50 AMIs Renalytix the best penny stock to buy today?uk.finance.yahoo.com - March 9 at 3:48 AMRNLX Mar 2024 2.500 callfinance.yahoo.com - February 17 at 1:44 AMRenalytix plc: Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024finanznachrichten.de - February 15 at 1:49 PMRenalytix AI plc (RENX)uk.investing.com - February 15 at 1:49 PMRenalytix Plc (RNLX) stock price, news, quote & history – Yahoo Financenz.finance.yahoo.com - February 14 at 2:56 PMRenalytix PLC RENXmorningstar.com - February 13 at 8:19 PMAfter the Renalytix share price jumps 500% in 3 days, is it time to buy?uk.finance.yahoo.com - February 13 at 3:19 PMRenalytix plc: New published data demonstrates KidneyIntelX has broad implications for winning war on chronic kidney diseasefinanznachrichten.de - January 10 at 10:46 AMRenalytix Stock (NASDAQ:RNLX) Earnings Dates and Earning Callsbenzinga.com - November 15 at 1:56 AMRenalytix Reports Full Year Fiscal 2023 Resultsmarkets.businessinsider.com - September 28 at 11:16 PMRenalytix Appoints Senior Executive Howard Doran as Chief Business Officerfinance.yahoo.com - September 7 at 9:16 AMRenalytix Appoints Financial Executive Catherine Coste to its Board of Directorsfinance.yahoo.com - July 3 at 9:28 AMFDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Diseasefinance.yahoo.com - June 29 at 7:36 PMKidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferencesfinance.yahoo.com - June 15 at 8:30 AMIs the Renalytix share price a bargain or a falling knife?uk.movies.yahoo.com - May 31 at 8:09 AMNew Published Real-World Evidence Shows KidneyIntelX(TM) Utilitymarketwatch.com - April 20 at 9:30 AMNew Published Real-World Evidence Shows KidneyIntelX™ Utilityfinance.yahoo.com - April 19 at 8:17 AMData Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meetingfinance.yahoo.com - April 12 at 10:47 AMRenalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Resultsfinance.yahoo.com - March 30 at 8:47 AMRenalytix Shares Fall on Delay to FDA Marketing Authorization Decision on KidneyIntelXmarketwatch.com - March 21 at 6:52 AMRenalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conferencefinance.yahoo.com - February 9 at 8:24 AMRenalytix announces a c.$20.3 million private placementfinance.yahoo.com - February 8 at 10:22 AMRenalytix Shares Rise on $10 Mln Grant Award to Advance Chronic Kidney Disease Treatmentmarketwatch.com - January 26 at 8:21 AMRenalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United Statesfinance.yahoo.com - January 26 at 8:21 AMRenalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systemsfinance.yahoo.com - January 9 at 7:31 AMPrimary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomesfinance.yahoo.com - December 1 at 11:32 AMRenalytix AI, Inc.: Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023finanznachrichten.de - November 30 at 11:23 AMWhat’s going on with the Renalytix share price?msn.com - November 30 at 11:23 AMRenalytix plc: Renalytix Reports Full Year Fiscal 2022 Resultsfinanznachrichten.de - October 31 at 6:53 PMRenalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31finance.yahoo.com - October 24 at 8:24 AMRenalytix Announces Change to Board of Directorsfinance.yahoo.com - September 20 at 9:14 AMRenalytix Plc (RENX.L)uk.finance.yahoo.com - August 17 at 7:46 PMData Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care Physiciansfinance.yahoo.com - August 8 at 5:50 PMHere’s why the Renalytix share price is tankingfool.co.uk - June 30 at 9:24 AMRenalytix Reports Financial Results for Third Quarter of Fiscal Year 2022finance.yahoo.com - June 30 at 9:24 AMThe Renalytix share price – where next?uk.finance.yahoo.com - June 16 at 2:34 PM1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patientsfinance.yahoo.com - June 10 at 9:41 AMKidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohortfinance.yahoo.com - June 6 at 8:15 AMRenalytix Announces Two Data Presentations on KidneyIntelX(TM) at American Diabetes Association 82nd Scientific Sessions®stockhouse.com - June 3 at 12:56 PMDan Levy Channeled His FOMO Into Directing His New Tostitos Ad: 'It's Very Real'yahoo.com - June 3 at 7:56 AMRenalytix plc successful completion of $30.0 million financing packagefinance.yahoo.com - April 8 at 6:31 PMRenalytix announces a $30.0 million financing packageca.finance.yahoo.com - March 31 at 10:25 AMFragrant Prosperity slumps as reverse takeover falls throughproactiveinvestors.com - March 10 at 10:53 PMKidneyIntelX™ Clinical Results Presented at World Congress of Nephrology Demonstrate Improved Prediction of Kidney Function Over Standard of Carefinance.yahoo.com - February 24 at 9:00 AMRenalytix Plc Share Chatlse.co.uk - February 22 at 11:54 PMPositive Study Results Published for KidneyIntelX™ in Monitoring Patient Response to New Drug Therapyfinance.yahoo.com - January 11 at 8:31 AMRenalytix to Present at 40th Annual J.P. Morgan Virtual Healthcare Conferencefinance.yahoo.com - January 5 at 8:05 AMRenalytix loss widens in first quarter amid higher R&D spendinglse.co.uk - December 9 at 8:51 AMSt. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New Yorkfinance.yahoo.com - November 9 at 8:07 AM Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here RENX Media Mentions By Week RENX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENX News Sentiment▼0.000.44▲Average Medical News Sentiment RENX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENX Articles This Week▼10▲RENX Articles Average Week Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cambridge Cognition News Today Induction Healthcare Group News Today Kooth News Today Redx Pharma News Today ANGLE News Today Arecor Therapeutics News Today Sareum News Today OKYO Pharma News Today C4X Discovery News Today Hemogenyx Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:RENX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
